Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism Muc18 inhibitors(Melanoma cell adhesion molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant Mesothelioma of Peritoneum | Preclinical | NO | 29 Oct 2024 | |
Malignant Mesothelioma of Peritoneum | Preclinical | NO | 29 Oct 2024 | |
Malignant Mesothelioma of Peritoneum | Preclinical | NO | 29 Oct 2024 |